Implementation of the ISTH classification of non-overt DIC in a thromboplastin induced rabbit model

Thrombosis Research

Volumn 124, Issue 4, 2009, Pages 490-497

  Olrik Berthelsen, Line ^a   Thuri Kristensen, Annemarie ^b   Wiinberg, Bo ^b   Tranholm, Mikael ^a  

^a NOVO NORDISK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Animal model; Disseminated intravascular coagulation (DIC); Non overt DIC; Rabbit; Thromboplastin

Indexed keywords

ANTITHROMBIN; ENDOTOXIN; FIBRINOGEN; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE FLUCTUATION; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISSEMINATED INTRAVASCULAR CLOTTING; DOSE RESPONSE; FEMALE; FIBRINOLYSIS; HISTOPATHOLOGY; LUNG BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCORING SYSTEM; THROMBOCYTE COUNT; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; DISSEMINATED INTRAVASCULAR COAGULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOGEN; PLATELET COUNT; PROTHROMBIN TIME; RABBITS; THROMBOPLASTIN; TIME FACTORS;

EID: 69249213501     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.05.012     Document Type: Article

References (21)

1. Levi M. Disseminated intravascular coagulation. Crit Care Med 35 9 (Sep 2007) 2191-2195
2. Bick R.L. Disseminated intravascular coagulation: a review of etiology, pathophysiology, diagnosis, and management: guidelines for care. Clin Appl Thromb Hemost 8 1 (Jan 2002) 1-31
3. Taylor Jr. F.B., Toh C.H., Hoots W.K., et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86 5 (Nov 2001) 1327-1330
4. Toh C.H., and Hoots W.K. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 5 3 (Mar 2007) 604-606
5. Taylor Jr. F.B., Chang A., Esmon C.T., et al. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79 3 (Mar 1987) 918-925
6. Spannagl M., Hoffmann H., Siebeck M., et al. A purified antithrombin III-heparin complex as a potent inhibitor of thrombin in porcine endotoxin shock. Thromb Res 61 1 (Jan 1 1991) 1-10
7. Warr T.A., Rao L.V., and Rapaport S.I. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood 75 7 (Apr 1 1990) 1481-1489
8. Emerson Jr. T.E. Effects of purified fibronectin alone and combined with immunoglobulin G or antithrombin-III on survival during gram-negative peritonitis or endotoxemia in rats. J Trauma 27 11 (Nov 1987) 1261-1266
9. Asakura H., Suga Y., Yoshida T., et al. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats. Blood Coagul Fibrinolysis 14 3 (Apr 2003) 221-228
10. Donati M.B., and Falanga A. Pathogenetic mechanisms of thrombosis in malignancy. Acta Haematol 106 1-2 (2001) 18-24
11. Hess J.R., Brohi K., Dutton R.P., et al. The coagulopathy of trauma: a review of mechanisms. J Trauma 65 4 (Oct 2008) 748-754
12. Kor-Anantakul O., and Lekhakula A. Overt disseminated intravascular coagulation in obstetric patients. J Med Assoc Thai 90 5 (May 2007) 857-864
13. Wiinberg B., Jensen A.L., Johansson P.I., et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 22 2 (Mar 2008) 357-365
14. Sandset P.M., Abildgaard U., and Pettersen M. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions. Thromb Res 47 4 (Aug 15 1987) 389-400
15. O'Brien P.J. Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker. Expert Rev Mol Diagn 6 5 (Sep 2006) 685-702
16. Pelzer H., Schwarz A., and Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost 59 1 (Feb 25 1988) 101-106
17. Siller-Matula J.M., Plasenzotti R., Spiel A., et al. Interspecies differences in coagulation profile. Thromb Haemost 100 3 (Sep 2008) 397-404
18. Feinstein D.I., Marder V.J., and Colman R.W. Consumptive thrombohemorrhagic disorders. In: Colman R.W., Hirsch J., Marder V.J., Clowes A.W., and George J.N. (Eds). hemostasis and thrombosis basic principles and clinical practice (2001), Lippincott Williams and Wilkins 1197-1233
19. Hoffmann S., Luderitz-Puchel U., Montag T., et al. Optimisation of pyrogen testing in parenterals according to different pharmacopoeias by probabilistic modelling. J Endotoxin Res 11 1 (2005) 25-31
20. Brutzki T.C., Kulczycky M.J., Bardossy L., et al. Rapid in vivo induction of leukocyte tissue factor mRNA and protein synthesis following low dose endotoxin administration to rabbits. Hematol J 2 3 (2001) 188-195
21. Clarke B.J., Sridhara S., Woskowska Z., et al. Consumption of plasma factor VII in a rabbit model of non-overt disseminated intravascular coagulation. Thromb Res 108 5-6 (Dec 15 2002) 329-334